Yes, recombination can significantly impact vaccine development and efficacy. A new recombinant strain may have antigens that are not well-matched by existing vaccines, reducing their effectiveness. This is why continuous monitoring and updating of vaccines, such as the annual flu vaccine, are necessary to keep up with the evolving virus.
